Impact of hyperaemic stenosis resistance on long-term outcomes of stable angina in the ILIAS Registry.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
03 Jun 2024
Historique:
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 6 6 2024
Statut: epublish

Résumé

The hyperaemic stenosis resistance (HSR) index was introduced to provide a more comprehensive indicator of the haemodynamic severity of a coronary lesion. HSR combines both the pressure drop across a lesion and the flow through it. As such, HSR overcomes the limitations of the more traditional fractional flow reserve (FFR) or coronary flow reserve (CFR) indices. We aimed to identify the diagnostic and prognostic value of HSR and evaluate the clinical implications. Patients with chronic coronary syndromes (CCS) and obstructive coronary artery disease were selected from the multicentre ILIAS Registry. For this study, only patients with combined Doppler flow and pressure measurements were included. A total of 853 patients with 1,107 vessels were included. HSR more accurately identified the presence of inducible ischaemia compared to FFR and CFR (area under the curve 0.71 vs 0.66 and 0.62, respectively; p<0.005 for both). An abnormal HSR measurement was an independent and important predictor of target vessel failure at 5-year follow-up (hazard ratio 3.80, 95% confidence interval: 2.12-6.73; p<0.005). In vessels deferred from revascularisation, HSR seems to identify more accurately those vessels that may benefit from revascularisation rather than FFR and/or CFR. The present study affirms the theoretical advantages of the HSR index for the detection of ischaemia-Âinducing coronary lesions in a large CCS population. (Inclusive Invasive Physiological Assessment in Angina Syndromes Registry [ILIAS Registry], ClinicalTrials.gov: NCT04485234).

Sections du résumé

BACKGROUND BACKGROUND
The hyperaemic stenosis resistance (HSR) index was introduced to provide a more comprehensive indicator of the haemodynamic severity of a coronary lesion. HSR combines both the pressure drop across a lesion and the flow through it. As such, HSR overcomes the limitations of the more traditional fractional flow reserve (FFR) or coronary flow reserve (CFR) indices.
AIMS OBJECTIVE
We aimed to identify the diagnostic and prognostic value of HSR and evaluate the clinical implications.
METHODS METHODS
Patients with chronic coronary syndromes (CCS) and obstructive coronary artery disease were selected from the multicentre ILIAS Registry. For this study, only patients with combined Doppler flow and pressure measurements were included.
RESULTS RESULTS
A total of 853 patients with 1,107 vessels were included. HSR more accurately identified the presence of inducible ischaemia compared to FFR and CFR (area under the curve 0.71 vs 0.66 and 0.62, respectively; p<0.005 for both). An abnormal HSR measurement was an independent and important predictor of target vessel failure at 5-year follow-up (hazard ratio 3.80, 95% confidence interval: 2.12-6.73; p<0.005). In vessels deferred from revascularisation, HSR seems to identify more accurately those vessels that may benefit from revascularisation rather than FFR and/or CFR.
CONCLUSIONS CONCLUSIONS
The present study affirms the theoretical advantages of the HSR index for the detection of ischaemia-Âinducing coronary lesions in a large CCS population. (Inclusive Invasive Physiological Assessment in Angina Syndromes Registry [ILIAS Registry], ClinicalTrials.gov: NCT04485234).

Identifiants

pubmed: 38840578
pii: EIJ-D-23-00713
doi: 10.4244/EIJ-D-23-00713
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04485234']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e699-e706

Auteurs

Coen K M Boerhout (CKM)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.

Mauro Echavarría-Pinto (M)

Hospital General ISSSTE Querétaro, Querétaro, Mexico and Facultad de Medicina, Universidad Autónoma de Querétaro, Querétaro, Mexico.

Guus A de Waard (GA)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Joo Myung Lee (JM)

Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Hernán Mejía-Rentería (H)

Hospital Clínico San Carlos IdISSC, Complutense University of Madrid and CIBERCV, Madrid, Spain.

Seung Hun Lee (S)

Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.

Ji-Hyun Jung (JH)

Sejong General Hospital, Sejong Heart Institute, Bucheon, Republic of Korea.

Masahiro Hoshino (M)

Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.

Hitoshi Matsuo (H)

Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.

Maribel Madera-Cambero (M)

Department of Cardiology, Tergooi Hospital, Blaricum, the Netherlands.

Ashkan Eftekhari (A)

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Mohamed A Effat (MA)

Division of Cardiovascular Health and Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.

Tadashi Murai (T)

Department of Cardiology, Tsuchiura Kyodo General Hospital, Tsuchiura City, Japan.

Koen Marques (K)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.

Joon-Hyung Doh (JH)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.

Evald H Christiansen (EH)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Rupak Banerjee (R)

Mechanical and Materials Engineering Department, University of Cincinnati, Cincinnati, OH, USA and Research Services, Veteran Affairs Medical Center, Cincinnati, OH, USA.

Chang-Wook Nam (CW)

Department of Internal Medicine and Cardiovascular Center, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.

Giampaolo Niccoli (G)

Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.

Masafumi Nakayama (M)

Cardiovascular Center, Toda Central General Hospital, Toda, Japan.
Department of Cardiology, Tokyo D Tower Hospital, Koto City, Japan.

Nobuhiro Tanaka (N)

Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.

Eun-Seok Shin (ES)

Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Marcel A M Beijk (MAM)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Paul Knaapen (P)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.

Javier Escaned (J)

Hospital Clínico San Carlos IdISSC, Complutense University of Madrid and CIBERCV, Madrid, Spain.

Tsunekzu Kakuta (T)

Department of Cardiology, Tsuchiura Kyodo General Hospital, Tsuchiura City, Japan.

Bon-Kwon Koo (BK)

Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.

Jan J Piek (JJ)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.

Tim P van de Hoef (TP)

Heart Center, Amsterdam UMC, Amsterdam, the Netherland.
Department of Cardiology, University Medical Centre Utrecht, Utrecht, the Netherlands.

Martijn Meuwissen (M)

Department of Cardiology, Amphia Hospital, Breda, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH